Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

This innovative bladder cancer diagnostic kit uses urine samples to achieve 88.8 % sensitivity, promising early detection and ...

Matt Galsky, MD, discusses the phase 3 NIAGARA trial that led to the recent FDA approval of durvalumab in muscle-invasive ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer.

AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...

AstraZeneca (NASDAQ:AZN) has reached a significant milestone with the U.S. approval of its drug Imfinzi for adult patients ...

AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

Army bomb disposal veterans may have a significantly increased risk of developing bladder cancer compared to the general ...